Tumor
📧 Sign up to get email alerts when something new happens for Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Artificial Intelligence-Guided Detection of Blood Vessels to Enhance Safety in Third-Space Endoscopic Procedures [NA]
A clinical trial in India is evaluating AI-guided detection of blood vessels to improve safety during third-space endoscopic procedures; it …
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Application of ⁶⁸Ga-FXX489 (NNS309) PET/CT Imaging in Diagnosis of Tumor Diseases. [Phase 1]
A Phase 1 clinical trial is evaluating the imaging agent 68Ga-FXX489 (NNS309) for PET/CT-based diagnosis of tumor and metastatic cancer, cur…
-
CLINICAL_TRIALS trial_result · 2025-07-29Clinical Trial Update: A Study of Live Tumor Fragments of Surgical Resections
A Mayo Clinic-sponsored clinical trial is recruiting to study live tumor fragments from surgical resections, exploring their potential utili…
-
CLINICAL_TRIALS trial_result · 2025-03-18Clinical Trial Update: Community Health Workers and Precision Medicine [NA]
A completed clinical trial sponsored by Stanford University evaluated the role of community health workers in precision medicine approaches …
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: 68Ga-FAP-RGD PET/CT : Dosimetry and Preliminary Clinical Translational Studies [Phase 1, Phase 2]
A clinical trial update for 68Ga-FAP-RGD PET/CT focusing on dosimetry and preliminary translational studies across Phase 1 and Phase 2.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2023-09-21Clinical Trial Update: 68Ga-FAP-CHX PET/CT : Dosimetry and Preliminary Clinical Translational Studies [Phase 1, Phase 2]
A clinical trial update for 68Ga-FAP-CHX PET/CT focusing on dosimetry and preliminary translational studies across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2023-06-07Clinical Trial Update: A Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial update for ASN002 in relapsed/refractory lymphoma and advanced solid tumors; the study status is TERMINATED with re…
-
CLINICAL_TRIALS trial_result · 2023-05-06Clinical Trial Update: Phase I/IIa Study for PM1032 in the Treatment of Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Phase I/IIa study update for PM1032 in patients with advanced solid tumors; early-stage clinical trial information with unknown status.
-
CLINICAL_TRIALS trial_result · 2023-02-28Clinical Trial Update: A Dose Escalation and Combination Immunotherapy Study to Evaluate BMS-986226 Alone or in Combination With Nivolumab or Ipilimumab in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A dose-escalation and combination immunotherapy trial evaluating BMS-986226 alone or with nivolumab or ipilimumab in advanced solid tumors w…
-
CLINICAL_TRIALS trial_result · 2022-10-26Clinical Trial Update: The HeLiX (Hemorrhage During Liver Resection: traneXamic Acid) Trial [Phase 3]
Phase 3 clinical trial update for the HeLiX trial evaluating tranexamic acid to reduce hemorrhage during liver resection.
-
CLINICAL_TRIALS trial_result · 2022-08-19Clinical Trial Update: Management of Preoperative Anaemia in Surgical Oncology [Phase 4]
A Phase 4 clinical trial update addressing management of preoperative anemia in patients undergoing surgical oncology.
-
CLINICAL_TRIALS trial_result · 2022-06-16Clinical Trial Update: Study of BMS-986158 in Subjects With Select Advanced Cancers [Phase 1, Phase 2]
Phase 1/2 study of BMS-986158 in subjects with advanced cancers has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2022-05-16Clinical Trial Update: NB1011 Administered by Continuous Infusion in Cancers That Overexpress Thymidylate Synthase (TS) [Phase 1, Phase 2]
Phase 1/2 trial evaluating NB1011 infused continuously in cancers overexpressing thymidylate synthase has completed.
-
CLINICAL_TRIALS trial_result · 2022-05-02Clinical Trial Update: A Study of Vorinostat in Patients With Solid Tumors (MK-0683-029) [Phase 1]
Phase 1 trial update of vorinostat in patients with solid tumors has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-03-04Clinical Trial Update: Efficacy and Safety of Precision Therapy in Refractory Tumor [Phase 2]
Phase 2 trial update on a precision therapy showing efficacy and safety in refractory tumors.
-
CLINICAL_TRIALS trial_result · 2021-08-17Clinical Trial Update: A Study of Ramucirumab (LY3009806) in Children With Refractory Solid Tumors [Phase 1]
Phase 1 study of ramucirumab in pediatric patients with refractory solid tumors has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-11-30Clinical Trial Update: Pharmacokinetic Study on the Addition of Aprepitant to Cisplatin - Etoposide Treatment in Lung Cancer Patients [Phase 4]
Phase 4 pharmacokinetic study evaluating adding aprepitant to cisplatin-etoposide in cancer patients has been terminated.
-
CLINICAL_TRIALS trial_result · 2020-06-12Clinical Trial Update: the Efficacy and Safety of 5-HT3 Receptor Antagonist, Dexamethasone or Megestrol Acetate Dispersible Tablets in the Control of Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of a 5-HT3 receptor antagonist, dexamethasone, or dispersible tablets of megestrol…
-
CLINICAL_TRIALS trial_result · 2020-02-21Clinical Trial Update: Dexmedetomidine and Propofol for Pediatric MRI Sedation [Phase 4]
Phase 4 trial assessing Dexmedetomidine and Propofol for pediatric MRI sedation has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Prophylaxis of CHB Patients With Malignant Tumor Receiving Chemotherapy [Phase 4]
Phase 4 clinical trial update on prophylaxis for chronic hepatitis B patients with malignant tumors receiving chemotherapy.
-
CLINICAL_TRIALS trial_result · 2019-06-17Clinical Trial Update: A Study of LY2334737 in Participants With Cancer That is Advanced and/or Has Spread [Phase 1]
Phase 1 trial update for LY2334737 in advanced/metastatic cancer; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2019-05-21Clinical Trial Update: A Phase II Study of Anlotinib in MTC Patients [Phase 2]
Phase II study of anlotinib in tumor patients has completed.
-
CLINICAL_TRIALS trial_result · 2018-11-02Clinical Trial Update: the Efficacy and Safety of Sugammadex in Children 0-2 Years Old [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluating the efficacy and safety of sugammadex in children aged 0-2 years for anesthesia-related use, wit…
-
CLINICAL_TRIALS trial_result · 2012-06-21Clinical Trial Update: Evaluation of the Safety and Efficacy of Oshadi D and Oshadi R for Cancer Treatment [Phase 1]
Phase 1 trial completed evaluating the safety and preliminary efficacy of Oshadi D and Oshadi R for cancer.